Calidi Biotherapeutics Inc Share Price Today: Live Updates & Key Insights

Calidi Biotherapeutics Inc share price today is $0.1, up -4.76%. The stock opened at $0.1055 against the previous close of $0.105, with an intraday high of $0.1108 and low of $0.0952.

Calidi Biotherapeutics Inc Share Price Chart

Calidi Biotherapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Calidi Biotherapeutics Inc Share Price Performance

$0.1 -0.0476(-4.76%) CLDI at 27 Jul 2026 02:27 PM Biotechnology
Lowest Today 0.0952
Highest Today 0.1108
Today’s Open 0.1055
Prev. Close 0.105
52 Week High 10.92
52 Week Low 0.10
Day’s Range: Low 0.0952 High 0.1108
52-Week Range: Low 0.10 High 10.92
1 day return -
1 Week return -14.01
1 month return -38.56
3 month return -58.58
6 month return -90.25
1 year return -81.91
3 year return -99.05
5 year return -98.98
10 year return -

Calidi Biotherapeutics Inc Institutional Holdings

Calidi Biotherapeutics Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Calidi Biotherapeutics Inc Fundamentals

Market Cap 2.03 M

PB Ratio 0.4132

PE Ratio 0.0

Enterprise Value -2.33 M

Total Assets 8.86 M

Volume 40137491

Calidi Biotherapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY21:449000 0.4M, FY20:0 0.0M

Annual Profit FY23:0 0.0M, FY21:355000 0.4M, FY20:0 0.0M

Annual Net worth FY23:-29216000 -29.2M, FY21:-10933000 -10.9M, FY20:-7937000 -7.9M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-426000 -0.4M, Q3/2025:-427000 -0.4M, Q2/2025:-407000 -0.4M, Q1/2025:-394000 -0.4M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-4108000 -4.1M, Q3/2025:-5149000 -5.1M, Q2/2025:-5715000 -5.7M, Q1/2025:-4986000 -5.0M, Q3/2024:-5054000 -5.1M

About Calidi Biotherapeutics Inc & investment objective

Company Information Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 29

Industry Biotechnology

CEO Dr. Eric E. Poma Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Calidi Biotherapeutics Inc FAQs

What is the share price of Calidi Biotherapeutics Inc today?

The current share price of Calidi Biotherapeutics Inc is $0.1.

Can I buy Calidi Biotherapeutics Inc shares in India?

Yes, Indian investors can buy Calidi Biotherapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Calidi Biotherapeutics Inc shares in India?

You can easily invest in Calidi Biotherapeutics Inc shares from India by:

Can I buy fractional shares of Calidi Biotherapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Calidi Biotherapeutics Inc?

Calidi Biotherapeutics Inc has a market cap of $2.03 M.

In which sector does Calidi Biotherapeutics Inc belong?

Calidi Biotherapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Calidi Biotherapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Calidi Biotherapeutics Inc?

The PE ratio of Calidi Biotherapeutics Inc is N/A and the PB ratio is 0.41.